Ensysce Biosciences reduces stockholder quorum to 1/3 of votes, effective Nov 1, 2024

Ensysce Biosciences, Inc.

Bylaw amendment lowers quorum from majority to 1/3 of total votes entitled to be cast.
Change approved by board on October 17, 2024; effective November 1, 2024.
No other amendments or fiscal year changes were reported.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Ensysce Biosciences, Inc.: Reduced stockholder meeting quorum requirement from majority to 1/3 of total votes entitled to be cast (effective 2024-11-01).

Change: bylaw amendment
Effective: 2024-11-01

Exact text from the filing

On October 17, 2024, Ensysce Biosciences, Inc. (the “ Company ” or “ we ”) amended its bylaws, effective November 1, 2024, to reduce the number of shares needed to constitute a quorum at meetings of stockholders from a majority of the total votes entitled to be cast to 1/3 rd of the total votes entitled to be cast.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Ensysce Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-041589

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.